Sydenham Emma, Roberts Ian, Alderson Phil
Cochrane Injuries Group, London School of Hygiene & Tropical Medicine, Room 280, Keppel Street, London, UK, WC1E 7HT.
Cochrane Database Syst Rev. 2009 Jan 21(1):CD001048. doi: 10.1002/14651858.CD001048.pub3.
Hypothermia has been used in the treatment of head injury for many years. Encouraging results from small trials and laboratory studies led to renewed interest in the area and some larger trials.
To estimate the effect of mild hypothermia for traumatic head injury on mortality and long-term functional outcome complications.
We searched the Injuries Group Specialised Register, Current Controlled Trials MetaRegister of trials, Zetoc, Web of Knowledge; Science Citation Index [expanded], CENTRAL, MEDLINE and EMBASE. We handsearched conference proceedings and checked reference lists of relevant articles. The search was updated on 23 May 2008.
Randomised controlled trials of hypothermia to a maximum of 35 degrees C for at least 12 hours versus control in patients with any closed traumatic head injury requiring hospitalisation. Two authors independently assessed all trials.
Data on death, Glasgow Outcome Scale and pneumonia were sought and extracted, either from published material or by contacting the investigators. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each trial on an intention-to-treat basis.
We found 22 trials with a total of 1409 randomised patients. Twenty trials involving 1382 patients reported deaths. There were fewer deaths in patients treated with hypothermia than in the control group (OR 0.76, 95% CI 0.60 to 0.97). Eight trials with good allocation concealment showed a non-significant reduction in the likelihood of death for patients treated with hypothermia (OR 0.96, 95% CI 0.68 to 1.35). Twenty trials involving 1382 patients reported data on unfavourable outcomes (death, vegetative state or severe disability). Patients treated with hypothermia were less likely to have an unfavourable outcome than those in the control group (OR 0.69, 95% CI 0.55 to 0.86). Eight trials with good allocation concealment showed a non-significant reduction in the likelihood of unfavourable outcome for patients treated with hypothermia (OR 0.79, 95% CI 0.57 to 1.08). Hypothermia treatment was associated with an increase in odds of pneumonia but this increase was not statistically significant for trials with good allocation concealment (3 trials, 69 patients, OR 1.06, 95% CI 0.38 to 2.97).
AUTHORS' CONCLUSIONS: Hypothermia may be effective in reducing death and unfavourable outcomes for traumatic head injured patients, but significant benefit was only found in low quality trials. Low quality trials have a tendency to overestimate the treatment effect. The high quality trials found some statistically non-significant benefit of hypothermia which could be due to the play of chance. Hypothermia may increase the risk of pneumonia. Due to uncertainties in its effects, hypothermia should only be given to patients taking part in a randomised controlled trial with good allocation concealment.
多年来,低温疗法一直用于治疗头部损伤。小型试验和实验室研究取得的鼓舞人心的结果引发了对该领域以及一些更大规模试验的新兴趣。
评估轻度低温疗法对创伤性头部损伤患者死亡率、长期功能结局及并发症的影响。
我们检索了损伤组专业注册库、当前对照试验元注册库、Zetoc、知识网络;科学引文索引(扩展版)、Cochrane系统评价中心对照试验注册库、医学索引数据库和荷兰医学文摘数据库。我们手工检索了会议论文集并查阅了相关文章的参考文献列表。检索于2008年5月23日更新。
针对任何需要住院治疗的闭合性创伤性头部损伤患者,进行体温降至最高35摄氏度并持续至少12小时的低温疗法与对照的随机对照试验。两位作者独立评估所有试验。
从已发表资料或通过联系研究者获取并提取关于死亡、格拉斯哥预后量表及肺炎的数据。对每项试验按意向性分析计算比值比(OR)和95%置信区间(CI)。
我们找到22项试验,共1409例随机分组患者。20项涉及1382例患者的试验报告了死亡情况。低温治疗组患者的死亡人数少于对照组(OR 0.76,95%CI 0.60至0.97)。8项分配隐藏良好的试验显示,低温治疗患者的死亡可能性有非显著性降低(OR 0.96,95%CI 0.68至1.35)。20项涉及1382例患者的试验报告了不良结局(死亡、植物状态或严重残疾)的数据。低温治疗组患者出现不良结局的可能性低于对照组(OR 0.69,95%CI 0.55至0.86)。8项分配隐藏良好的试验显示,低温治疗患者出现不良结局的可能性有非显著性降低(OR 0.79,95%CI 0.57至1.08)。低温治疗与肺炎发生率增加相关,但对于分配隐藏良好的试验,这种增加无统计学意义(3项试验,69例患者,OR 1.06,95%CI 0.38至2.97)。
低温疗法可能对降低创伤性头部损伤患者的死亡率和不良结局有效,但仅在低质量试验中发现显著益处。低质量试验往往高估治疗效果。高质量试验发现低温疗法有一些无统计学意义的益处,这可能是由于机遇因素。低温疗法可能增加肺炎风险。鉴于其效果存在不确定性,低温疗法仅应给予参与分配隐藏良好的随机对照试验的患者。